Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pKM2L-phPTGS1 (#RDB05501)

Promoter Bank clone, Human prostaglandin-endoperoxide synthase 1 (PTGS1) promoter

Alternative name p1912-3F
Clone info. PCR amplified human prostaglandin-endoperoxide synthase 1 (PTGS1) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 122370053 to 122371084(NC_000009.12); relatively -952 to +80, where +1 corresponds to 1 nt of NM_000962.3.
Comment PCR cloning, forward primer, H5PB0040F: 5' ttggacctattccttcctccttcta 3'; reverse primer, H5PB0040R: 5' ggcgcggctgctggggtgcggg 3'; Entire sequence of promoter region has not been confirmed. Promoter activity has not been analyzed.
Vector backbone pKM2L (RDB04026) (Plasmid)
Size of vector backbone 4.2 kb
Selectable markers Kan^r
Gene/insert name Human prostaglandin-endoperoxide synthase 1 genomic DNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB05501 pKM2L-phPTGS1 DNA solution JPY 9,460 (not-for-profit academic purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pKM2L-phPTGS1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05501).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB05501_B0Ggp1-1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: pUC-M13_-100 (Pr0310)
Region: insert 5'
Sequence file: RDB05501_B0Gga.seq check
>05501_05501_B0Gg_1_pUC-M13_-100_A09_03_ABI24.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNGNNNNNN NNNNNNNNNN NCCTGCNNGN CATTTAAATA
   61 GGGATAACAN GNNNNNNGAT NAAGATCTCG AGCTCTAAGC TTCACATATG CATGCACTAG
  121 TGGCTTGTAC CTATTCCTTC CTCCTTCTAG GTGCTTCCTG AGCTGGCGAA AAGGAGAGCT
  181 GGATGCTGGG ATTCTATAAA TTCGGCGGTG GATGTGAGTC TAGCTACAGC ATGGACCCTG
  241 GCCAGCCCTG GAATCTGAGT TCAGAGATCT TTGAAAAAAT GCCTTCCGAT AACTGAGCAC
  301 CTACTACATG CTGGACACTG CACCAGGAGA TTTGTGTGCA TTCCCTCATT GAATCTTACA
  361 ACCACCCTCT GGGATGGTTT TTGCTATTAA GCCGATTTTA TAGATGAGAA TACTGAGGGC
  421 TAGAAAAGAT AAGTACCTTG TCCAAGGTGA CACGGCCAGT AAGCTGTGGA GTCTGGATTT
  481 GAACTAGGCT CTCTTGGANT TTGGAGCCCG GTCTTTTCAT TTCTGGCAGA GACCTGTGGC
  541 TTCNGGGGGC GGAGCCCAGC CCATGGGGGA AGTAAGTCCT TCCTGTTAGA TCTGTCTGAN
  601 GANTAGTGAG TTTCTCATCT AGGAAAACCA TCAGCAGGCC AGGCTGGACT GCNNCNTTTC
  661 TAGCCCCCTT TCTTCTCTGC NGACTGCCCT GTTTCTANCC CCTTTTCTTC TCTACCCTTT
  721 NCTGTNNAGT GCGTTAGANC CATTTTACNG AANNNGNNTC TGANACCCTT TCNTNTCTGC
  781 NGGGGCAGGG TATGTGNNTN NNANGANCCG CTNNCATCCN NNNNNNTCTG NNCCNAANNC
841 CCNNNNGTGA NCNNCNNNCN NTNGANNNNC NNTCNCNNNN NNNNNN
//
Primer: hRluc_N_rev (Pr0567)
Region: hRluc, intron, insert 3'
Sequence file: RDB05501_B0Ggb.seq check
>05501_05501_B0Gg_1_hRluc_N_rev_B09_06_ABI24.ab1
    1 NNNNNNNNNN NNNNTNNNNT TGNNGCGNNC CCNCNACTGN NGCCCAGTGN TCATGCGTTT
   61 GCGTTGCTCG GGGTCGTACA CCTTGGAAGC CATGGTGGCT AGCCTATAGT GAGTCGTATT
  121 AAGTACTCTA GCCTTAAGAG CTGTAATTGA ACTGGGAGTG GACACCTGTG GAGAGAAAGG
  181 CAAAGTGGAT GTCAGTAAGA CCAATAGGTG CCTATCAGAA ACGCAAGAGT CTTCTCTGTC
  241 TCGACAAGCC CAGTTTCTAT TGGTCTCCTT AAACCTGTCT TGTAACCTTG ATACTTACCT
  301 GCCCAGTGCC TCACGACCAA CTTCTGCAGT ACCCGGGTGA ATTCTACGCG TCGACAGGCG
  361 GCTCGGCTGC TGGGGTGCGG GACGCAGAGT GCAGGCTCCT GTGCGTGCGC CTCGCACACT
  421 GCCCGGAGCT CCAGCCCATC CCCTCCCCAC CCTTCCCCCG GCTCCACCCC CGCTCCTCCC
  481 TCCAGCTGTC ACCTCGGCTG CCCGCTTACT TCCTCTGCCC AGCCCCGGCC AAGGCATTTT
  541 ATTAATTAGT GTATGCTCGC CGCTAAAGCG GCTTTTCACC CAAGATCCTT GAAGCACTTA
  601 CGTTTCTGAT GCCTGGTGGC ACTAGATATA GACAGGAAAC TGANGCTCAG AGACGATGCT
  661 CAATGCTGAN GTCACCCAGG GCTTANGGAC AGAACTGGGG ATGGAAGCGG CTCGTCTGAA
  721 CCACATACCC TGCCCCGCAN ANAAGAAAGG GTCTCAGANT CNNCTTCTGT AAAATGNNTC
  781 TAACGCACTC TACAGAAAAN GGTAGAGAAG AAAANGGGCT ANNAACAGGN CANNCTGCAN
  841 ANAANAAAGG GGGNTANAAA NGGGGGCANN NNANCNNNNN NNNGCNNNNG NNTTCNNNNN
901 NNNNAAANTC ANTANNCCNN NNNNNNNN
//
Primer: pAxCALNLF1 (Pr0166)
Region: hRluc
Sequence file: RDB05501_B0Ggc.seq check
>05501_05501_B0Gg_1_pAxCALNLF1_C09_09_ABI24.ab1
    1 NNNNNNNNNN NNNNNNGNNC TGCTNNNNNN GGCCGCTCTA GAATTACTGC TCGTTCTTCA
   61 GCACGCGCTC CACGAAGCTC TTGATGTACT TACCCATTTC ATCTGGAGCG TCCTCCTGGC
  121 TGAAGTGGAG GCCCTTCACC TTCACGAACT CGGTGTTAGG GAACTTCTTA GCTCCCTCGA
  181 CAATAGCGTT GGAAAAGAAC CCAGGGTCGG ACTCGATGAA CATCTTAGGC AGATCGTCGC
  241 TGGCCCGAAG GTAGGCGTTG TAGTTGCGGA CAATCTGGAC GACGTCGGGC TTGCCTCCCT
  301 TAACGAGAGG GATCTCGCGA GGCCAGGAGA GGGTAGGCCG TCTAACCTCG CCCTTCTCCT
  361 TGAATGGCTC CAGGTAGGCA GCGAACTCCT CAGGCTCCAG TTTCCGCATG ATCTTGCTTG
  421 GGAGCATGGT CTCGACGAAG AAGTTATTCT CAAGCACCAT TTTCTCGCCC TCTTCGCTCT
  481 TGATCAGGGC GATATCCTCC TCGATGTCAG GCCACTCGTC CCAGGACTCG ATCACGTCCA
  541 CGACACTCTC AGCATGGACG ATGGCCTTGA TCTTGTCTTG GTGCTCGTAG GAGTAGTGAA
  601 AGGCCAGACA AGCCCCCCAG TCGTGGCCCA CAAAGATGAT TTTCTTTGGA AGGTTCAGCA
  661 GCTCGAACCA AGCGGTGAGG TACTTGTAGT GATCCAGGAN GCGATATGAG CCATTCCCGC
  721 TCTTGCCGGA NTTACNCATT CCGATCAGAT CANGGNTGAT GCATCTAGCC ACGGGCTCNN
  781 TGTGANGCAC GACNNGNNNC CACAGGNAGC TGGNNGCAGC GTTACCATGC ANAAAANTCA
  841 CGGNNTTCNC GGCNNNNTNN NNNNNNTCAT ANNANTNNAT GNANNNANNC CNNNNNNNNN
901 ATTTNNCTNN NANNNNNNNN NN
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles